Cargando…
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
Autores principales: | Polonio‐Alcalá, Emma, Solé‐Sánchez, Sònia, Muñoz‐Guardiola, Pau, Megías‐Roda, Elisabet, Perez‐Montoyo, Héctor, Yeste‐Velasco, Marc, Alfón, Jose, Lizcano, Jose Miguel, Domènech, Carles, Ruiz‐Martínez, Santiago, Puig, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198345/ https://www.ncbi.nlm.nih.gov/pubmed/35293148 http://dx.doi.org/10.1002/cac2.12282 |
Ejemplares similares
-
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis
por: París-Coderch, Laia, et al.
Publicado: (2020) -
Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models
por: Mancini, Andrea, et al.
Publicado: (2022) -
ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress
por: Gámez-García, Andrés, et al.
Publicado: (2021) -
Metabolic bifunctionality of Rv0812 couples folate and peptidoglycan biosynthesis in Mycobacterium tuberculosis
por: Black, Katherine A., et al.
Publicado: (2021) -
Screening of Additive Manufactured Scaffolds Designs for Triple Negative Breast Cancer 3D Cell Culture and Stem-Like Expansion
por: Polonio-Alcalá, Emma, et al.
Publicado: (2018)